NRX Pharmaceuticals Inc (NAS:NRXP) Stock News, Headlines & Updates
NRX Pharmaceuticals Inc Stock News from GuruFocus
- 1
Aug 15, 2024
NRX Pharmaceuticals Inc (NRXP) Q2 2024 Earnings Call Transcript Highlights: Significant Cost Reductions and New Funding Boost
GuruFocus Research • 1:00pm
Q2 2024 NRX Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research • 11:18am
Aug 14, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
PRNewswire • 4:00pm
Aug 13, 2024
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024
PRNewswire • 4:00pm
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds
PRNewswire • 7:00am
Jul 29, 2024
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)
PRNewswire • 8:00am
HOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics Spinoff
PRNewswire • 8:00am
Jul 01, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
PRNewswire • 8:00am
Jun 28, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
PRNewswire • 8:00am
Jun 20, 2024
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
PRNewswire • 8:00am
Jun 18, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors
PRNewswire • 8:00am
Jun 10, 2024
NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
PRNewswire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news